Telix Pharmaceuticals Limited (TLPPF)
USD 15.71
(0.0%)
USD 15.71
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.88 Million | -63.97 Million | -59.32 Million | 1.96 Million | -23.33 Million | -20.74 Million |
| Net Income | 5.21 Million | -104.07 Million | -80.51 Million | -44.88 Million | -27.86 Million | -13.82 Million |
| Depreciation & Amortization | 6.92 Million | 5.37 Million | 5.17 Million | 4.88 Million | 4.23 Million | 6928.00 |
| Deferred income taxes | -8.78 Million | -8.11 Million | -1.32 Million | -2.34 Million | -1.26 Million | - |
| Stock-based compensation | 8.78 Million | 8.11 Million | 1.32 Million | 2.34 Million | 1.26 Million | 712 Thousand |
| Change in working capital | -33.5 Million | -1 Million | -2.63 Million | 31.81 Million | -361 Thousand | -4.26 Million |
| Other non-cash items | 45.25 Million | 35.73 Million | 18.63 Million | 10.15 Million | 659 Thousand | 136.77 Thousand |
| Investing Cash Flow | -25.48 Million | -16.99 Million | -2.72 Million | -1.09 Million | -468 Thousand | -2.69 Million |
| Investments in PPE | -10.79 Million | -13.86 Million | -1.33 Million | -322 Thousand | -468 Thousand | - |
| Acquisitions | - | -973 Thousand | - | -322 Thousand | - | -2.69 Million |
| Investment purchases | -13.15 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.54 Million | -2.16 Million | -1.38 Million | -447 Thousand | -65 Thousand | - |
| Financing Cash Flow | 10.18 Million | 174.96 Million | 2.84 Million | 34.11 Million | 42.72 Million | -869.35 Thousand |
| Debt repayment | -5.75 Million | -13 Thousand | -340 Thousand | -402 Thousand | -943 Thousand | -869.35 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -7.81 Million | - | -130 Thousand | - | - |
| Common Stock Issuance | 6.65 Million | 181.03 Million | 3.78 Million | 35.15 Million | 45.25 Million | - |
| Other Financing Activities | 9.29 Million | 4.76 Million | -596 Thousand | -502 Thousand | -1.58 Million | - |
| Accounts receivables | -27.38 Million | -19.93 Million | -7.19 Million | -328 Thousand | -3.63 Million | -7.22 Million |
| Accounts payables | 33.7 Million | 30.45 Million | 7.48 Million | 1.67 Million | 2.97 Million | 4.43 Million |
| Inventory | -9.63 Million | -5.02 Million | -2.82 Million | -91 Thousand | 101 Thousand | - |
| Other working capital | -30.19 Million | -6.5 Million | -101 Thousand | 30.55 Million | 198 Thousand | -1.48 Million |
| Cash at beginning of period | 116.32 Million | 22.03 Million | 77.94 Million | 44.59 Million | 25.77 Million | 48.75 Million |
| Cash at end of period | 123.23 Million | 116.32 Million | 22.03 Million | 77.94 Million | 44.59 Million | 25.77 Million |
| Capital Expenditure | -10.79 Million | -13.86 Million | -1.33 Million | -322 Thousand | -468 Thousand | - |
| Effect of forex changes on cash | -1.67 Million | 299 Thousand | 3.3 Million | -1.63 Million | -95 Thousand | 1.32 Million |
| Net cash flow / Change in cash | 6.9 Million | 94.29 Million | -55.9 Million | 33.34 Million | 18.82 Million | -22.98 Million |
| Free Cash Flow | 13.09 Million | -77.83 Million | -60.66 Million | 1.63 Million | -23.8 Million | -20.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.68 Million | 17.97 Million | 19.53 Million | 5.21 Million | 9.76 Million | -14.32 Million |
| Depreciation & Amortization | 2.42 Million | 1.33 Million | 3.63 Million | 6.92 Million | 1.77 Million | 3.28 Million |
| Deferred income taxes | - | - | 17.75 Million | -8.78 Million | - | - |
| Stock-based compensation | 7.24 Million | 2.69 Million | 3.73 Million | 8.78 Million | 3.73 Million | 655.5 Thousand |
| Change in working capital | - | - | -28.76 Million | -33.5 Million | -28.76 Million | - |
| Other non-cash items | 12.25 Million | -11.17 Million | -5.26 Million | 45.25 Million | 18.8 Million | 30.86 Million |
| Investing Cash Flow | -36.92 Million | -8.91 Million | -22.6 Million | -25.48 Million | -11.3 Million | -2.88 Million |
| Investments in PPE | -2.3 Million | -6.92 Million | -7.78 Million | -10.79 Million | -3.33 Million | -3 Million |
| Acquisitions | -23.18 Million | - | -123 Thousand | - | -61.5 Thousand | 123 Thousand |
| Investment purchases | 4000.00 | -1.99 Million | -13.15 Million | -13.15 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -11.43 Million | -6.53 Million | -1.54 Million | -1.54 Million | -7.9 Million | - |
| Financing Cash Flow | 3.61 Million | -1.46 Million | 5.48 Million | 10.18 Million | 2.74 Million | 4.7 Million |
| Debt repayment | -1.5 Million | -1.19 Million | -3.27 Million | -5.75 Million | - | -2.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.29 Million | -2.66 Million | 3.72 Million | 6.65 Million | - | 2.92 Million |
| Other Financing Activities | 2.11 Million | -2.66 Million | 2.74 Million | 9.29 Million | 2.74 Million | 2.35 Million |
| Accounts receivables | - | - | -13.69 Million | -27.38 Million | -13.69 Million | - |
| Accounts payables | - | - | - | 33.7 Million | - | - |
| Inventory | - | - | -4.81 Million | -9.63 Million | -4.81 Million | - |
| Other working capital | - | - | -10.25 Million | -30.19 Million | -10.25 Million | - |
| Cash at beginning of period | 122.7 Million | 127.61 Million | 131.72 Million | 116.32 Million | - | 116.32 Million |
| Cash at end of period | 118.83 Million | 122.7 Million | 123.23 Million | 123.23 Million | -4.24 Million | 131.72 Million |
| Capital Expenditure | -2.3 Million | -6.92 Million | -7.78 Million | -10.79 Million | -3.33 Million | -3 Million |
| Effect of forex changes on cash | -4.16 Million | 4.37 Million | -999.5 Thousand | -1.67 Million | -999.5 Thousand | 163 Thousand |
| Net cash flow / Change in cash | -3.87 Million | -4.9 Million | -8.49 Million | 6.9 Million | -4.24 Million | 15.4 Million |
| Free Cash Flow | 31.3 Million | -1.44 Million | 2.84 Million | 13.09 Million | 1.97 Million | 10.25 Million |
TAPG
2160
HRME
ASHNI
STT-PG
SMBC